To print this article, all you need is to be registered or login on Mondaq.com.
As we previously reported, President Biden
recently signed into law a $1.9 trillion dollar stimulus bill,
the
American Rescue Plan Act (ARPA).
This historic legislative package provides much needed relief to
millions of Americans impacted by the COVID-19 pandemic and
essential resources to address the ongoing public health emergency.
Among other things, the ARPA allocates funds to the Department of
Health and Human Services (HHS) for COVID-19 testing, contact
tracing, vaccines, supplies, and other related treatment. To
alleviate the strain of the COVID-19 pandemic on America s
The ACCC 47
th Annual Meeting & Cancer Center
Business Summit (AMCCBS) took place virtually, March 1-5. The
Summit serves the prominent thought leadership forum and annual
conference on matters of policy, business strategies, business
models, hospital alignment, and best business practices in
community oncology.
The Next Wave in Oncology Transactions - Marketplace
Considerations, Transaction Structures and Antitrust
Foley Partner Adria Warren, along with Curtis Bernstein
(Principal at Pinnacle Healthcare Consulting), Josh Eaves (Senior
VP, Strategic Partnerships and Acquisitions at Alliance Oncology),
and Brad Prechtl (CEO at American Oncology Network, LLC), explored
the newest trends and opportunities available to community
providers and hospitals in oncology transactions.
To print this article, all you need is to be registered or login on Mondaq.com.
A new Florida law provides civil immunity from
COVID-related lawsuits to defendants that complied in good faith
with government health standards, and it imposes heightened
pleading and proof requirements on plaintiffs.
On March 29, 2021, Florida enacted new legislation (codified at
Florida Statutes § 768.38) adopting heightened legal
protections for defendants facing COVID-related lawsuits. Most
significantly, the law provides civil immunity to all persons,
businesses, educational institutions, governmental entities, and
religious institutions that made a good faith effort to
substantially comply with government-issued health standards
or guidance. A separate section of the legislation (codified at
Seyfarth Synopsis:
This announcement
extends the flexibilities in rules relating to Form I-9 compliance
that was initially granted last year. It also expands the scope of
the in-person exemption benefit to certain employees,
and offers flexibility for companies that are phasing back in
employees, as doing so will no longer trigger the in-person
requirement for all new hires. While an improvement in the
overall dialogue, the guidance leaves uncertainty regarding the end
of I-9 virtual flexibility, and as such, employers should consider
moving away from the virtual completion model while continuing to
heavily document current practices.
With employers impatiently waiting, the U.S. Immigration and
For more than a year, the world has reacted to and adjusted for COVID-19. Now, with the arrival of COVID-19 vaccines, there is light at the end of the tunnel and individuals and companies can start.